Paper Title
Treatment Of Active Pulmonary And Extra-Pulmonary Tuberculosis with Co-morbidities in Adult Patients Admitted to The Government Tertiary Care Hospital in Mandya: A Cross-Sectional Study
Article Identifiers
Authors
DR. AJAY GOPINATH , KAVITHA SEKAR , MADEEHA ABRAR , MIDHUNA T , DR. BLESSIN V SHERVIN
Keywords
Tuberculosis, Extra pulmonary tuberculosis, Comorbidities, National Tuberculosis Elimination Programme (NTEP), World Health Organization (WHO).
Abstract
Tuberculosis (TB) has been a health problem that, despite all global efforts, they claimed 1.3 million deaths globally in 2020, with an increase to 1.4 million people in 2021. Due to difficulty in diagnosis and treatment of TB cases during Coronavirus pandemic in 2019, it reversed years of progress in the field. Tuberculosis is communicable disease caused by the bacteria Mycobacterium tuberculosis which commonly affects the lungs. The treatment of tuberculosis is complicated by many factors, and it is very crucial to evaluate the effectiveness of drug therapy to improve the quality of life for the tuberculosis patients. Adults who are suffering with multiple disease states are known to suffer more from tuberculosis infection hence, an appropriate treatment must be provided for such patients. The main objective of the study is to enhance the knowledge regarding tuberculosis’s association with co-morbidities. And also, to describe the treatment pattern involved in it. In a tertiary care hospital, a cross sectional study was conducted for a duration of 6 months which involved 90 tuberculosis affected patients with various co-morbidities. The study assesses the presence of different co-morbidities and their treatment pattern in the individual patient by collecting the data from the patient’s medical record. Statistical analysis i.e., descriptive analysis was done. The primary outcomes were to assess the prescribed drugs for the treatment of active pulmonary (PTB) and extra-pulmonary tuberculosis (EPTB) and secondary outcomes were focused on the association of tuberculosis with co-morbidities and their treatment pattern. The present study showed that among 90 patients, 30% of patients had extra-pulmonary tuberculosis and 70% of patients had pulmonary tuberculosis. The majority of the co-morbidities with tuberculosis were under respiratory system-related diseases (48.8%). Most of the patients were with anaemia (35.5%). In conclusion, co-morbidities are present in many tuberculosis patients and are associated with poor quality of life and increased morbidity. Identification and correction of co-morbidities is based on treating the underlying cause which may improve their clinical outcome.
Downloads
How To Cite (APA)
DR. AJAY GOPINATH, KAVITHA SEKAR, MADEEHA ABRAR, MIDHUNA T, & DR. BLESSIN V SHERVIN (November-2023). Treatment Of Active Pulmonary And Extra-Pulmonary Tuberculosis with Co-morbidities in Adult Patients Admitted to The Government Tertiary Care Hospital in Mandya: A Cross-Sectional Study. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(11), b301-b307. https://ijnrd.org/papers/IJNRD2311139.pdf
Issue
Volume 8 Issue 11, November-2023
Pages : b301-b307
Other Publication Details
Paper Reg. ID: IJNRD_208672
Published Paper Id: IJNRD2311139
Downloads: 000122014
Research Area: Pharmacy
Country: Mandya, Karnataka, India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2311139.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2311139
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Licence
This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.
Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: October 2025
Current Issue: Volume 10 | Issue 10 | October 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 31-Oct-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
